Sasser JM, Ni X, Humphreys MH, Baylis C. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to a nitric oxide donor in the pregnant rat. Am J Physiol Renal Physiol 299: F810 -F814, 2010. First published July 28, 2010 doi:10.1152/ajprenal.00117.2010.-Pregnancy is characterized by plasma volume expansion and renal sodium retention with loss of natriuretic response to atrial natriuretic peptide due to increased medullary phosphodiesterase-5 (PDE5). Here, we determined whether natriuretic responses to nitric oxide (NO) are also blunted in pregnancy due to increased PDE5. Anesthetized 16-day pregnant and virgin rats were studied at baseline and during intrarenal infusion of the NO donor spermine NONOate (2.5 nmol/min), the PDE5 inhibitor sildenafil (SILD; 0.5 g/min), or a combination. The right (noninfused) kidney served as a control. Intrarenal NONOate had no effect on mean arterial pressure (MAP); however, SILD reduced MAP in virgin rats, and the combination of NONOateϩSILD reduced MAP in both virgin and pregnant rats. Neither NONOate nor SILD altered glomerular filtration rate. NONOate and SILD each stimulated sodium excretion (UNaV) and fractional excretion of sodium (FENa) in virgin rats, but the combination did not result in an additional natriuretic response. However, NONOate infusion did not increase UNaV or FENa in pregnant rats, but the natriuretic response to NONOate was restored with SILD, and SILD alone produced a natriuresis during pregnancy. Sodium nitroprusside (10 Ϫ4 mol/l)-stimulated cGMP accumulation from inner medullary collecting duct cells was blunted in cells from pregnant vs. virgin or postpartum rats and was restored by treatment with the PDE5 inhibitor DMPPO (10 Ϫ7 mol/l). Therefore, increased intrarenal PDE5 mediates the blunted natriuretic response to NO, and loss of responsiveness to the cGMP-dependent, natriuretic agents may contribute to volume expansion during pregnancy. spermine NONOate; sodium nitroprusside; cGMP; inner medulla; sodium retention; sildenafil DURING NORMAL PREGNANCY, WOMEN undergo a progressive plasma volume expansion. This increase in circulating volume begins in the first trimester, peaks near gestational week 32, and remains elevated until term to meet the demands of fetal development (12,24). Failure to expand plasma volume is correlated with complications of pregnancy and intrauterine growth restriction (4, 15). Experimental animal models also exhibit plasma volume expansion during pregnancy, and this is due to net continual renal sodium and fluid retention (1).Previous findings in our laboratory and from others have indicated that in normal pregnancy the natriuretic response to atrial natriuretic peptide (ANP) and the pressure-natriuresis response are blunted, therefore promoting sodium retention and plasma volume expansion (6,17,18,22,23). Pressureinduced natriuresis is dependent on the renal tubular actions of nitric oxide (NO, 16). While it is likely that the tubular responsiveness to NO is blunted in pregnancy based on th...